Bavarian Nordic CEO notes progress in vaccine funding talks with Danish government

Monday, Bavarian Nordic presented promising data for the company's Covid-19 vaccine candidate. Danish state aid could play a role in helping the vaccine reach the public, and the firm's CEO says the talks are going well.
Bavarian Nordic CEO Paul Chaplin. | Photo: Bavarian Nordic / PR
Bavarian Nordic CEO Paul Chaplin. | Photo: Bavarian Nordic / PR
BY ANDREAS LØNSTRUP, TRANSLATED BY DANIEL FRANK CHRISTENSEN

The prospect of a Danish vaccine against Covid-19 is now one step closer to reality on Monday, when pharmaceutical company Bavarian Nordic presented a bundle of promising data. At the same time, the firm's talks with the Danish government concerning state financial support for the vaccine are progressing well, says Bavarian Nordic Chief Executive Paul Chaplien, reports Danish business daily Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading